Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Abstract Text:

Bolan Yu,Birgit M Dietz,Tareisha Dunlap,Irida Kastrati,Daniel D Lantvit,Cassia R Overk,Ping Yao,Zhihui Qin,Judy L Bolton,Gregory R J Thatcher,

The benzothiophene selective estrogen receptor modulators (SERM) raloxifene and arzoxifene are in clinical use and clinical trials for chemoprevention of breast cancer and other indications. These SERMs are "oxidatively labile" and therefore have potential to activate antioxidant responsive element (ARE) transcription of genes for cytoprotective phase II enzymes such as NAD(P)H-dependent quinone oxidoreductase 1 (NQO1). To study this possible mechanism of cancer chemoprevention, a family of benzothiophene SERMs was developed with modulated redox activity, including arzoxifene and its metabolite desmethylarzoxifene (DMA). The relative antioxidant activity of these SERMs was assayed and correlated with induction of NQO1 in murine and human liver cells. DMA was found to induce NQO1 and to activate ARE more strongly than other SERMs, including raloxifene and 4-hydroxytamoxifen. Livers from female, juvenile rats treated for 3 days with estradiol and/or with the benzothiophene SERMs arzoxifene, DMA, and F-DMA showed substantial induction of NQO1 by the benzothiophene SERMs. No persuasive evidence in this assay or in MCF-7 breast cancer cells was obtained of a major role for the estrogen receptor in induction of NQO1 by the benzothiophene SERMs. These results suggest that arzoxifene might provide chemopreventive benefits over raloxifene and other SERMs via metabolism to DMA and stimulation of ARE-mediated induction of phase II enzymes. The correlation of SERM structure with antioxidant activity and NQO1 induction also suggests that oxidative bioactivation of SERMs may be modulated to enhance chemopreventive activity.

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Publishing Authors By Initials

B Yu,BM Dietz,T Dunlap,I Kastrati,DD Lantvit,CR Overk,P Yao,Z Qin,JL Bolton,GR Thatcher,

For similar cells: cells, cultured: tumor cells, cultured research abstracts see: cells: cells, cultured: tumor cells, cultured research

PUBMED ID PMID:

MEDLINE DATE:

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Molecular cancer therapeutics

VOLUME: 6

Page Numbers: 2418-28

Journal Abbreviation: Mol. Cancer Ther.

ISSN: 1535-7163

DAY: 27

MONTH: Sep

YEAR: 2007

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101132535

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Keywords Mesh Terms:

KEYWORDS: Tumor Cells, Cultured

MESH TERMS: drug effects

Chemical & Substance for Abstract: Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms. Information

Substance Name: NQO1 protein, human

Registry Number: EC 1.6.99.2

Grant and Affiliation Information for Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.

AFFILIATION: Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA 79870

ACRONYM: CA

MEDLINETA: Mol Cancer Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms Related Publications

• Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
• Antibiotics in foods: a review of some public health aspects.
• Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity.
• Cloned ovarian cells from sheep: Cholesterol dependency in progesterone synthesis.
• Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo.
• Concentration of phenylbutazone (PBZ) and 13, 14-dihydro-15 keto PGF(2alpha) (PGFM) in blood and seminal plasma of stallions treated with PBZ.
• Cortical reorganization in deaf children.
• Effects of calving-related disorders on prostaglandin, calcium, ovarian activity and uterine involution in postrartum dairy cows.
• Effects of dietary unsaturated fatty acids on oocyte quality and follicular development in lactating dairy cows in summer.
• Effects of postinsemination progesterone supplementation on fertility and subsequent estrous responses of dairy heifers.
• Embryonic development in superovulated dairy cattle exposed to elevated ambient temperatures between Days 1 to 7 post insemination.
• Fetal survival in the cow after pregnancy diagnosis by palpation per rectum.
• Follicular dynamics and superovulatory response in Holstein cows treated with FSH-P in different endocrine states.
• HEALTH PROBLEMS IN THE FOOD INDUSTRY.
• Influence of summer heat stress on pregnancy rates of lactating dairy cattle following embryo transfer or artificial insemination.
• Influences of in vitro oocyte aging on microfertilization in the mouse with reference to zona hardening.
• Potential mechanisms of estrogen quinone carcinogenesis.
• Pregnancy, bovine somatotropin, and dietary n-3 Fatty acids in lactating dairy cows: III. Fatty acid distribution.
• Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lactating dairy cows: I. Ovarian, conceptus, and growth hormone-insulin-like growth factor system responses.
• Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lactating dairy cows: II. Endometrial gene expression related to maintenance of pregnancy.
• Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection.
• Regulation of heat shock-induced alterations in the release of prostaglandins by the uterine endometrium of cows.
• Secretion of PGF2alpha and oxytocin during hyperthermia in cyclic and pregnant heifers.
• Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.
• Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.
• Survival improvement in thoracic cancer: progress from the last decade and beyond.
• The effects of ACTH on the renin-aldosterone system in normotensive man.
• The long-term pattern of adult mortality and the highest attained age.
• The place of targeted therapy in the patient management of non-small cell lung cancer.
• The role of potassium as cause of death in experimental trypanosomiasis.